Barinthus Biotherapeutics plc. SEC Filings

Filed On	Filing
21 Sep 2026	15-12G
14 Sep 2026	EFFECT
11 Sep 2026	SCHEDULE 13G/A
11 Sep 2026	Form 4/A: Oxford Science Enterprises plc, former 10% owner Disposed of 8,797,770 shares (Tender Offer) ($977K)
09 Sep 2026	FORM 25
09 Sep 2026	Form 4: Wright Robin, Director Returned 48,256 shares to the issuer · Disposed of 132,213 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	Form 4: Scheeren Joseph, Director Returned 23,000 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	Form 4: Phillips Anne M., Director Returned 3,000 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	Form 4: Morgon Pierre A., Director Returned 10,506 shares to the issuer · Disposed of 132,213 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	Form 4: Hooftman Leon, Chief Medical Officer Received 361,530 shares as a grant or award · Returned 361,530 shares to the issuer · Disposed of 335,166 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	Form 4: Hammacher Alex, Director Returned 3,000 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	Form 4: Enright William, Director Returned 1,243,377 shares to the issuer · Disposed of 2,019,716 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	S-8 POS
09 Sep 2026	S-8 POS
09 Sep 2026	S-8 POS
09 Sep 2026	S-8 POS
09 Sep 2026	S-8 POS
09 Sep 2026	POS AM
09 Sep 2026	Form 4: Dawes Karen A, Director Returned 1,700 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer)
09 Sep 2026	8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference.

Comments